DK0994703T3 - Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS - Google Patents

Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS

Info

Publication number
DK0994703T3
DK0994703T3 DK99916036T DK99916036T DK0994703T3 DK 0994703 T3 DK0994703 T3 DK 0994703T3 DK 99916036 T DK99916036 T DK 99916036T DK 99916036 T DK99916036 T DK 99916036T DK 0994703 T3 DK0994703 T3 DK 0994703T3
Authority
DK
Denmark
Prior art keywords
crps
ketanserin
carnitine
treatment
composition
Prior art date
Application number
DK99916036T
Other languages
English (en)
Inventor
Claudio Cavazza
Menotti Calvani
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of DK0994703T3 publication Critical patent/DK0994703T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
DK99916036T 1998-04-10 1999-04-08 Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS DK0994703T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT98MI000774A IT1299069B1 (it) 1998-04-10 1998-04-10 Composizione farmaceutica per il trattamento della "sindrome dolorosa regionale cronica" ("chronic regional pain syndrome crps")
PCT/IT1999/000084 WO1999052517A2 (en) 1998-04-10 1999-04-08 Composition comprising ketanserin and l-carnitine or an alkanoyl l-carnitine for the treatment of crps

Publications (1)

Publication Number Publication Date
DK0994703T3 true DK0994703T3 (da) 2003-11-03

Family

ID=11379743

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99916036T DK0994703T3 (da) 1998-04-10 1999-04-08 Sammensætning omfattende ketanserin og L-carnitin til behandlingen af CRPS

Country Status (16)

Country Link
US (2) US6214884B1 (da)
EP (1) EP0994703B1 (da)
JP (1) JP4482163B2 (da)
KR (1) KR100573010B1 (da)
AT (1) ATE244566T1 (da)
AU (1) AU742013B2 (da)
BR (1) BR9906350A (da)
CA (1) CA2292638C (da)
DE (1) DE69909395T2 (da)
DK (1) DK0994703T3 (da)
ES (1) ES2203115T3 (da)
IL (1) IL133141A (da)
IT (1) IT1299069B1 (da)
NZ (1) NZ501416A (da)
PT (1) PT994703E (da)
WO (1) WO1999052517A2 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004084905A2 (en) * 2003-03-24 2004-10-07 University Of Florida Use of 5-ht2c receptor activity affecting compounds for treating idiopathic hyperhidrosis and associated conditions
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
CN1686139B (zh) * 2005-04-30 2012-07-11 福建师范大学 酮色林在治疗炎性疼痛的新型镇痛药中的应用
KR20240100931A (ko) 2022-12-23 2024-07-02 주식회사 일리아스바이오로직스 슈퍼-리프레서(super-repressor, SR)-IκB(srIκB)를 포함하는 엑소좀의 복합부위통증증후군에 대한 치료적 용도

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5973004A (en) * 1997-04-04 1999-10-26 Howard; James R. L-carnitine, acetyl-L-carnitine, and pantothenic acid or ubiquinone, combined for prevention and treatment of syndromes related to ineffective energy metabolism

Also Published As

Publication number Publication date
CA2292638A1 (en) 1999-10-21
WO1999052517A3 (en) 2000-01-06
ATE244566T1 (de) 2003-07-15
JP2002504934A (ja) 2002-02-12
JP4482163B2 (ja) 2010-06-16
HK1026608A1 (en) 2000-12-22
DE69909395T2 (de) 2004-06-09
EP0994703B1 (en) 2003-07-09
IL133141A (en) 2006-06-11
US6214884B1 (en) 2001-04-10
PT994703E (pt) 2003-11-28
WO1999052517A2 (en) 1999-10-21
KR20010013685A (ko) 2001-02-26
BR9906350A (pt) 2000-09-19
US20040209906A1 (en) 2004-10-21
DE69909395D1 (de) 2003-08-14
CA2292638C (en) 2008-08-26
ES2203115T3 (es) 2004-04-01
AU742013B2 (en) 2001-12-13
ITMI980774A1 (it) 1999-10-10
EP0994703A2 (en) 2000-04-26
IL133141A0 (en) 2001-03-19
IT1299069B1 (it) 2000-02-07
NZ501416A (en) 2002-03-01
KR100573010B1 (ko) 2006-04-24
AU3442699A (en) 1999-11-01

Similar Documents

Publication Publication Date Title
IS1812B (is) Meðferðaefnasambönd, lyfjafræðilega hæf sölt og samsetningar sem innihalda efnasamböndin, ásamt notkun þeirra
DK0927150T3 (da) Lipoxinforbindelser og deres anvendelse til behandling af celleformeringsforstyrrelser
EE03741B1 (et) N-propargüül-1-aminoindaani R-enantiomeeri, sellesoolade ja kompositsioonide kasutamine
GR3034854T3 (en) Arylidene and heteroarylidene oxindole derivatives as tyrosine kinase inhibitors.
TR200102711T2 (tr) Kriz halindeki başağrılarının iyileştirilmesinde kullanıma yönelik antikonvülsan türevler
DK1000039T3 (da) Substituerede quinazolinderivater og anvendelse deraf som tyrosinkinaseinhibitorer
DE69925133D1 (de) Pyrrolobenzodiazepine
ID28981A (id) Turunan-turunan heksana 3-azabisiklo (3.1.0) yang berguna dalam terapi
EE200200414A (et) Dihüdro-1,3,5-triasiinamino derivaadid ja nende kasutamine ravis
ATE231872T1 (de) Thiazolopyrimidinderivate
DK0736525T3 (da) Benzonitriler som 5-HT-agonister og -antagonister
ZA9911B (en) 2,3-substituted indole compounds as anti-inflammatory and analgesic agents.
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
SE9802208D0 (sv) Novel compounds
IS5942A (is) 3,3-bíarýlpíperidín og 2,2-bíarýlmorfólín afleiður
DK1057813T3 (da) Indolderivater og medicinske sammensætninger indeholdende de samme
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
MA26666A1 (fr) Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
DK1214302T3 (da) Substituerede 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-oner og deres anvendelse som lipasehæmmere
NO20033184L (no) Anvendelse av forbindelsen (+)-<alfa>-(2,3-dimetoksyfenyl)-1- [2-(4-fluorfenyl)etyl]-4-piperidinmetanol
SE9802209D0 (sv) Novel compounds
PT994703E (pt) Composicao compreendendo ketanserina e l-carnitina para o tratamento de sdrc
DK0813870T3 (da) Anvendelse af darifenacin til at forstærke kognitive funktioner
EP0882711A4 (en) INDOLDER DERIVATIVES AND ROOTING AGENTS THAT CONTAIN THEM AS ACTIVE INGREDIENTS
NO20001176D0 (no) Anvendelse av blandinger av polymerer og aminoisothiasoler som biocider